These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Yukmijihwang-tang inhibits receptor activator for nuclear Factor-κB ligand-induced osteoclast differentiation. Shim KS, Ma CJ, Kim DS, Ma JY. J Med Food; 2011 Nov; 14(11):1439-47. PubMed ID: 21883017 [Abstract] [Full Text] [Related]
5. The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells. Kim HS, Suh KS, Sul D, Kim BJ, Lee SK, Jung WW. Int J Mol Med; 2012 Feb; 29(2):169-77. PubMed ID: 22038020 [Abstract] [Full Text] [Related]
10. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, Kim N, Lee SY. Blood; 2005 Aug 01; 106(3):852-9. PubMed ID: 15817678 [Abstract] [Full Text] [Related]
18. Anti-osteoclastic effect of caffeic acid phenethyl ester in murine macrophages depends upon the suppression of superoxide anion production through the prevention of an active-Nox1 complex formation. Kwon YB, Wang FF, Jang HD. J Nutr Biochem; 2018 Aug 01; 58():158-168. PubMed ID: 29957360 [Abstract] [Full Text] [Related]
19. Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ). Odkhuu E, Koide N, Haque A, Tsolmongyn B, Naiki Y, Hashimoto S, Komatsu T, Yoshida T, Yokochi T. Immunol Lett; 2012 Feb 29; 142(1-2):34-40. PubMed ID: 22193059 [Abstract] [Full Text] [Related]
20. Honokiol inhibits osteoclast differentiation and function in vitro. Hasegawa S, Yonezawa T, Ahn JY, Cha BY, Teruya T, Takami M, Yagasaki K, Nagai K, Woo JT. Biol Pharm Bull; 2010 Feb 29; 33(3):487-92. PubMed ID: 20190414 [Abstract] [Full Text] [Related] Page: [Next] [New Search]